Dnmt3a is an epigenetic mediator of adipose insulin resistance. by You, Dongjoo et al.
UC Berkeley
UC Berkeley Previously Published Works
Title
Dnmt3a is an epigenetic mediator of adipose insulin resistance.
Permalink
https://escholarship.org/uc/item/425580zx
Journal
eLife, 6
ISSN
2050-084X
Authors
You, Dongjoo
Nilsson, Emma
Tenen, Danielle E
et al.
Publication Date
2017-11-01
DOI
10.7554/eLife.30766
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
*For correspondence:
erosen@bidmc.harvard.edu (EDR);
kangs@berkeley.edu (SK)
Competing interests: The
authors declare that no
competing interests exist.
Funding: See page 14
Received: 26 July 2017
Accepted: 29 October 2017
Published: 01 November 2017
Reviewing editor: Clifford J
Rosen, Maine Medical Center
Research Institute, United States
Copyright You et al. This
article is distributed under the
terms of the Creative Commons
Attribution License, which
permits unrestricted use and
redistribution provided that the
original author and source are
credited.
Dnmt3a is an epigenetic mediator of
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Abstract Insulin resistance results from an intricate interaction between genetic make-up and
environment, and thus may be orchestrated by epigenetic mechanisms like DNA methylation. Here,
we demonstrate that DNA methyltransferase 3a (Dnmt3a) is both necessary and sufficient to
mediate insulin resistance in cultured mouse and human adipocytes. Furthermore, adipose-specific
Dnmt3a knock-out mice are protected from diet-induced insulin resistance and glucose intolerance
without accompanying changes in adiposity. Unbiased gene profiling studies revealed Fgf21 as a
key negatively regulated Dnmt3a target gene in adipocytes with concordant changes in DNA
methylation at the Fgf21 promoter region. Consistent with this, Fgf21 can rescue Dnmt3a-
mediated insulin resistance, and DNA methylation at the FGF21 locus was elevated in human
subjects with diabetes and correlated negatively with expression of FGF21 in human adipose
tissue. Taken together, our data demonstrate that adipose Dnmt3a is a novel epigenetic mediator
of insulin resistance in vitro and in vivo.
DOI: https://doi.org/10.7554/eLife.30766.001
Introduction
Insulin resistance (IR) is generally defined as a reduced ability of insulin to provoke metabolic
responses, such as glucose uptake. Several mechanistic drivers of IR have been proposed, including
defects in the insulin signal transduction pathway, dysfunctional mitochondrial respiration, and ER
stress (Boucher et al., 2014; Gregor and Hotamisligil, 2011; Houstis et al., 2006; Ozcan et al.,
2004; Samuel and Shulman, 2012). The data supporting the involvement of these non-mutually
exclusive pathways are convincing, but additional mechanisms are also likely to participate in the
development of IR. Nuclear pathways in particular (i.e. transcriptional and epigenomic mechanisms)
are likely to play an important role, given that IR often develops over a time course that is inconsis-
tent with rapid signal transduction events (Kang et al., 2015; Tan et al., 2015). Furthermore, there
is a large body of data from humans and rodents indicating that the propensity for IR can be passed
transgenerationally; such ‘fetal programming’ studies strongly imply an epigenetic basis for IR
(Carone et al., 2010; Heijmans et al., 2008; Li et al., 2010; Tobi et al., 2014). Finally, thiazolidine-
dione drugs, which activate the transcription factor PPARg, provide one of the only pharmacological
therapies for IR (Soccio et al., 2014; Step et al., 2014; Sugii et al., 2009). Taken together, these
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data strongly suggest that epigenomic and transcriptional mechanisms must be in play in the etiopa-
thogenesis of IR (Kang et al., 2016).
DNA methylation is a reversible epigenetic mark involving the covalent transfer of a methyl group
to the C-5 position of a cytosine residue, usually in the context of a CpG doublet, by DNA methyl-
transferases (Dnmts) (Robertson, 2005). Long thought to be a static epigenetic mark, emerging evi-
dence suggests that methylated DNA undergoes dynamic and reversible remodeling in somatic cells
during developmental, physiological, and pathogenic pathophysiological processes (Barres et al.,
2013; 2009; Benner et al., 2015; Kirchner et al., 2016; Multhaup et al., 2015; Siersbæk et al.,
2017). As an example, a bout of intense exercise can induce DNA hypomethylation at the
PPARGC1a locus in human skeletal muscle within hours, followed by increased gene expression;
these effects were reversed after resting (Barre`s et al., 2012). Mounting evidence points to a role
for DNA methylation in the pathogenesis of metabolic disorders. For example, the obesity-prone
agouti mouse has reduced DNA methylation at the regulatory region for the Agouti gene, leading
to enhanced expression and subsequent inhibition of the satiety-inducing MC4 receptor (Xie et al.,
2013). Multiple studies have shown that changes in DNA methylation at key metabolic genes, such
as Cox7a1 (Ro¨nn et al., 2008), IGF-2 (Heijmans et al., 2008), and Pomc (Ehrlich et al., 2010), asso-
ciate with various metabolic insults including aging, obesity, anorexia, and prenatal exposure to fam-
ine. Moreover, recent genome-wide profiling studies have identified distinct global DNA
methylation patterns that associate with obesity and diabetes in humans (Dayeh et al., 2014;
Feinberg et al., 2010; Kirchner et al., 2016; Multhaup et al., 2015; Nilsson et al., 2015;
Volkmar et al., 2012; Volkov et al., 2017). Altered DNA methylation is linked to the transgenera-
tional passage of metabolic disorders (Ng et al., 2010; Wei et al., 2014). Despite numerous studies
showing a link between DNA methylation and metabolic dysregulation, the cause-and-effect rela-
tionship between the two remains largely unknown.
In mammals, five Dnmt family members have been identified: Dnmt1, Dnmt2 (also known as
Trdmt1), Dnmt3a, Dnmt3b and Dnmt3l, yet only three (Dnmt1, 3a, and 3b) possess DNA methyl-
transferase activity (Robertson, 2005). Dnmt1 (the maintenance DNA methyltransferase) has a pref-
erence to methylate hemimethylated DNA whereas Dnmt3a and 3b prefer unmethylated DNA as
substrate, and thus act as de novo DNA methyltransferases (Robertson, 2005). Dnmt3l is homolo-
gous to the other Dnmt3s but lacks catalytic activity (Robertson, 2005) and Dnmt2 has sequence
homology to all Dnmts but methylates cytoplasmic tRNA, and not DNA (Robertson, 2005). Adminis-
tration of a small molecule Dnmt inhibitor has been shown to improve insulin sensitivity in the setting
of obesity, in part by demethylating the Adipoq promoter, and a role for Dnmt1 in this process was
suggested by genetic knockdown studies in cultured adipocytes (Kim et al., 2015).
Here, we identify Dnmt3a as a key epigenetic determinant of obesity-associated IR in adipose tis-
sue. Dnmt3a plays a causal role in the development of cell autonomous IR in mouse and human adi-
pocytes in a manner that is dependent on its catalytic activity. Consistent with results from
adipocytes in vitro, we find that adipose-specific Dnmt3a deficiency in vivo confers protection from
diet-induced IR and glucose tolerance without accompanying changes in body weight or adiposity.
In addition, unbiased gene expression profiling suggests that Dnmt3a acts as primarily as a gene
repressor, and reveals a set of adipocyte-specific target genes, including Fgf21. Further, we demon-
strate that Dnmt3a mediates IR, at least in part, by methylating specific cis-regulatory elements in
the Fgf21 gene and thus suppressing its expression. We also provide evidence that similar mecha-
nisms might be at play in human adipose tissue. These studies identify Dnmt3a as a novel epigenetic
mediator of IR in adipocytes.
Results
Adipose expression of Dnmts inversely correlates with insulin
sensitivity
To identify a potential role for Dnmts in the pathogenesis of insulin resistance, we compared their
expression levels in insulin-sensitive metabolic tissues (i.e. liver, muscle, and adipose depots) in vari-
ous metabolic settings. In a diet-induced obesity (DIO) mouse model, Dnmt1 and Dnmt3a mRNA
expression was elevated in adipose tissue, especially in epididymal and mesenteric WAT (Figure 1A,
Figure 1—figure supplement 1A). Dnmt3a expression was significantly induced by HFD in skeletal
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muscle, but to a lesser degree than in adipose tissue. No effect of HFD was observed in liver (Fig-
ure 1—figure supplement 1B–C). In genetically obese ob/ob mice, mRNA expression of all three
functional Dnmts was elevated in adipose tissue (Figure 1B). Importantly, expression of these genes
was significantly reduced after treatment with the insulin sensitizer rosiglitazone (Rosi) (Figure 1B).
Increased adipose expression of Dnmt3a was confirmed by immunoblotting in DIO mice (Figure 1C,
D). Relative expression of Dnmt3a was higher in eWAT compared to skeletal muscle and liver com-
pared in normal chow-fed mice (Figure 1—figure supplement 1D–E). Dnmt2 and Dnmt3l mRNA
displayed minimal expression in adipose tissue (not shown). Together, this led us to hypothesize that
Dnmts may have a direct functional role in the pathogenesis of adipose IR.
Dnmt3a 
Actin 
Chow HFD 
!
"
#
$%
&'
(
#
)#
*
+
,#
-
-
'.
/
"
#
$%
&'
(
#
)#
*
+
,#
-
-
'.
/
4
5 !"#$%&
'()* +,!
-
.
/
%
0
!
"
#
$%
&
12
13
4
$5
"
6
D
n
m
t1
D
n
m
t3
a
D
n
m
t3
b
0
1
2
3 Chow
HFD*
*
D
nm
t1
D
nm
t3
a
D
nm
t3
b
0
2
4
6
ob/+
ob/ob
ob/+ (+) Rosi
ob/ob (+) Rosi*
*
*
*
*
*
7
#849
#849 #849
Figure 1. Increased adipose expression of Dnmts in obesity. (A) Dnmt mRNA expression in adipose from chow- and high fat-fed (HFD) C57Bl/6 mice
(A); n = 6 mice, p<0.05, Student’s t-test, mean ±s.e.m.) and (B) in adipose tissue from ob/+and ob/ob mice in the presence and absence of
rosiglitazone treatment (right; n = 7 for ob/+, n = 8 for ob/+plus Rosi, n = 7 for ob/ob with and without Rosi, p<0.05, Student’s t-test, mean ±s.e.m.). (C)
Western blot showing Dnmt3a protein levels in adipose tissue from chow vs. HFD mice. (D) Quantification of western blot in (C).
DOI: https://doi.org/10.7554/eLife.30766.002
The following source data and figure supplements are available for figure 1:
Source data 1. Figure 1—source data.
DOI: https://doi.org/10.7554/eLife.30766.005
Figure supplement 1. Expression of Dnmts in various metabolic tissues.
DOI: https://doi.org/10.7554/eLife.30766.003
Figure supplement 1—source data 1. Figure 1—figure supplement 1—source data.
DOI: https://doi.org/10.7554/eLife.30766.004
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Knock-down of Dnmt3a confers protection from drug-mediated IR
Given the inverse correlation of adipose Dnmt expression with insulin sensitivity, we sought to test
the cell autonomous role of Dnmts in the development of IR. To that end, individual Dnmts were
knocked-down in mature 3T3-L1 adipocytes using two distinct short hairpin RNAs (shRNAs) (Fig-
ure 2—figure supplement 1A–F). To promote IR, cells were treated with dexamethasone (Dex) and
TNF-a (TNF) (Houstis et al., 2006; Kang et al., 2015) for an additional four days. Knock-down of
individual Dnmts did not have a major impact on the basal level of insulin sensitivity when assessed
by insulin-stimulated glucose uptake (Figure 2—figure supplement 2A–E). However, knock-down of
Dnmt3a, but not Dnmt1 or Dnmt3b, protected adipocytes from Dex- and TNF-mediated IR as
assessed by insulin-stimulated glucose uptake and signal transduction (Figure 2A,B, Figure 2—fig-
ure supplement 2A–E). Given the elevated expression of adipose Dnmts in obesity, we were
prompted to test whether overexpression of Dnmts per se is sufficient to drive IR in adipocytes. Indi-
vidual Dnmts were expressed in mature 3T3-L1 adipocytes by lentiviral delivery. Interestingly, over-
expression of Dnmt3a and 3b, but not Dnmt1, potently inhibited insulin-stimulated glucose uptake
(Figure 2C). Additionally, we tested whether the causal role of Dnmt3a in the development of insulin
resistance is conserved in human adipocytes. Overexpression of Dnmt3a powerfully inhibited insulin-
stimulated glucose uptake in in vitro differentiated adipocytes from human adipose derived stem
cells (Figure 2D). Together, our gain- and loss-of-function studies in vitro show that Dnmt3a is both
necessary and sufficient to mediate IR in adipocytes in a cell autonomous manner.
DNA methyltransferase activity is critical for Dnmt3a to mediate IR
Studies have shown that Dnmt3a can act as a gene repressor using both catalytic-dependent and
independent mechanisms (Bachman et al., 2001; Fuks et al., 2001). Thus, we sought to determine
whether DNA methyltransferase activity is required to mediate IR. We initially pursued a pharmaco-
logical approach, using two synthetic Dnmt inhibitors, 5-azacytidine (5-Aza) (Stresemann and Lyko,
2008), a nucleoside analogue serving as a pseudo-substrate for Dnmts, and RG-108
(Brueckner et al., 2005), a non-nucleoside-based drug. Remarkably, both Dnmt inhibitors blocked
Dex- and TNF-mediated IR (Figure 3A,B, Figure 3—figure supplement 1A,B). In addition to these
synthetic inhibitors, the naturally occurring Dnmt inhibitors (Rajavelu et al., 2011) epigallocatechin
gallate (ECCG) and theaflavin-3,30-digallate (TF-3) also showed insulin-sensitizing activity in the set-
ting of Dex- and TNF-mediated IR (Figure 3—figure supplement 1C–F). These data suggest that
DNA methyltransferase activity is necessary for Dnmt3 to cause IR. To further probe this hypothesis,
we overexpressed a catalytically inactive allele of Dnmt3a (C706S) (Hsieh, 1999). Unlike the wild-
type allele, Dnmt3a C706S was unable to suppress insulin-stimulated glucose uptake (Figure 3C).
Together, the pharmacological and genetic evidence indicates that DNA methyltransferase activity is
essential for Dnmt3a to mediate IR.
Adipose-specific Dnmt3a deficiency confers protection from diet-
induced insulin resistance and glucose intolerance
We next sought to determine whether loss of Dnmt3a in adipocytes could confer protection from
diet-induced adipose tissue and systemic IR in vivo. To address this, we generated adipose-specific
Dnmt3a knock-out mice (Dnmt3aAdiKO) by crossing Dnmt3a floxed mice (Dnmt3af/f) (Nguyen et al.,
2007) to adiponectin-Cre mice (Eguchi et al., 2011) (Figure 4—figure supplement 1A,B). On chow
diet, male WT and Dnmt3aAdiKO animals did not show any obvious change in their body weight, insu-
lin sensitivity, glucose tolerance, or insulin levels (Figure 4—figure supplement 2A–D). On HFD
(45% fat), Dnmt3aAdiKO mice still showed no significant differences in body weight or composition
relative to littermate controls (Figure 4A,B). Moreover, the effect of long-term fasting (16 hr) on
body weight or body composition did not differ between genotypes (Figure 4C), suggesting that
gross energy homeostasis is not altered in the knock-out animals. Despite no obvious change in
energy balance, high fat fed male Dnmt3aAdiKO mice exhibited improved glucose tolerance
(Figure 4D,E) and insulin sensitivity (Figure 4F,G) with reduced serum insulin in the fed state
(Figure 4H). Consistent with their metabolic improvement, male Dnmt3aAdiKO mice display increased
insulin signal transduction in adipose tissue, as demonstrated by increased insulin-stimulated phos-
phorylation of IRS and AKT (Figure 4I,J). Similarly, female Dnmt3aAdiKO mice display improved insu-
lin sensitivity and glucose tolerance on HFD without a change in body weight (Figure 4—figure
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Figure 2. Dnmt3a is sufficient and necessary to mediate cell autonomous IR in vitro. (A) Two independent hairpins against Dnmt3a (versus scrambled
control shRNA; shScr) were delivered to mature 3T3-L1 adipocytes (Day 8) via lentiviral transduction. Cells were then treated with Dex and TNF for 4
days and assessed for insulin-stimulated glucose uptake (3H-2-DG assay, n = 6, p<0.05). Shown is the % of insulin-stimulated glucose uptake rescued
by Dnmt3a knockdown (n = 6, p<0.05). (B) Cells in (A) with #2 shDnmt3a hairpin and control cells were withdrawn from serum for 6 hr, stimulated with
20 nM insulin for 5 min and subjected to immunoblotting with antibodies against total and phospho-AKT and –IRS-1 with and without insulin. (C) Basal
and insulin-stimulated glucose uptake in mature 3T3-L1 and (D) in in vitro-differentiated primary human adipocytes transduced with lentivirus
expressing Dnmts or the empty plasmid vector, pCDH (n = 6, p<0.05, Student’s t-test, mean ±s.e.m.).
DOI: https://doi.org/10.7554/eLife.30766.006
The following source data and figure supplements are available for figure 2:
Source data 1. Figure 2—source data.
DOI: https://doi.org/10.7554/eLife.30766.011
Figure supplement 1. Knock-down efficiency of Dnmt hairpins.
DOI: https://doi.org/10.7554/eLife.30766.007
Figure supplement 1—source data 1. Figure 2—figure supplement 1—source data.
DOI: https://doi.org/10.7554/eLife.30766.008
Figure supplement 2. Dnmt3a is necessary for Dex- and TNF-mediated IR.
DOI: https://doi.org/10.7554/eLife.30766.009
Figure supplement 2—source data 1. Figure 2—figure supplement 2—source data.
DOI: https://doi.org/10.7554/eLife.30766.010
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supplement 3A–C). We next assessed whether insulin sensitization could be due to either enhanced
browning or reduced inflammation of WAT. With regard to the former, we found no consistent
change in the expression of major thermogenic genes such as Ucp1 and Ppargc1a in either iWAT
and BAT (Figure 4—figure supplement 4A,B). Additionally, gene expression analysis showed a non-
significant trend toward reduced expression of proinflammatory genes such as Tnfa and Ccl2 (which
encodes MCP-1) in the eWAT of Dnmt3aAdiKO mice (Figure 4—figure supplement 5A). We also saw
no obvious change in the density of crown-like structures between WT and KO tissues (Figure 4—
figure supplement 5B). Together, these results demonstrate that adipose-specific deletion of
Dnmt3a confers protection from diet-induced IR in a manner that is independent of adiposity,
inflammation, or browning of white adipose tissue.
Unbiased gene profiling studies reveal that Fgf21 is a key metabolic
target gene of Dnmt3a in adipocytes
Dnmt3a affects developmental processes by regulating non-overlapping sets of cell type-specific tar-
get genes (Challen et al., 2011; Nguyen et al., 2007; Nishikawa et al., 2015). To gain mechanistic
insight into Dnmt3a-mediated IR at the molecular level, we performed RNA-seq in 3T3-L1 adipo-
cytes, in both gain- and loss-of-function contexts. We have successfully used this approach to
enhance our ability to identify bona fide targets (Kang et al., 2012). We found that 97 genes were
repressed after shRNA-mediated Dnmt3a knock-down, while only eight genes were up-regulated in
the presence of excess Dnmt3a; the single gene showing concordant regulation was Dnmt3a itself
(Figure 5A). Conversely, 290 genes were induced by Dnmt3a knock-down, and 36 genes showed
diminished expression after Dnmt3a overexpression; seven genes were concordantly regulated by
both manipulations (Figure 5B and C and Supplementary file 1). These data are consistent with the
expectation that Dnmt3a works primarily as a repressor of gene expression. Among the concor-
dantly-regulated negative target genes of Dnmt3a, we were immediately struck by the presence of
Fgf21. FGF21 is known to facilitate glucose uptake in adipocytes (Ge et al., 2011; Lee et al., 2014;
Minard et al., 2016), and is a positive target gene of PPARg (Muise et al., 2008). Furthermore,
mice lacking FGF21 do not support Rosi-mediated insulin sensitization in vivo (Dutchak et al.,
2012). We confirmed by Q-PCR that Fgf21 expression is indeed reduced in cultured adipocytes
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Figure 3. DNA methyltransferase activity is critical for Dnmt3a to mediate IR. Insulin-stimulated glucose uptake assay was conducted using 3T3-L1
adipocytes treated with Dnmt inhibitors (A, 5-Aza; B, RG-108) and Dex or TNF for 4 days. Shown is the % of insulin-stimulated glucose uptake rescued
by Dnmt inhibitors (n = 6, p<0.05). (C) Basal and insulin-stimulated glucose uptake in mature 3T3-L1 adipocytes transduced with wild-type Dnmt3a vs. a
catalytically inactive allele (C706S) (n = 6, p<0.05, Student’s t-test, mean ±s.e.m.).
DOI: https://doi.org/10.7554/eLife.30766.012
The following source data and figure supplements are available for figure 3:
Source data 1. Figure 3—source data.
DOI: https://doi.org/10.7554/eLife.30766.015
Figure supplement 1. Dnmt inhibitors confer protection from Dex- and TNF-mediated IR.
DOI: https://doi.org/10.7554/eLife.30766.013
Figure supplement 1—source data 1. Figure 3—figure supplement 1—source data.
DOI: https://doi.org/10.7554/eLife.30766.014
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Figure 4. Adipose-specific Dnmt3a KO mice display improved whole body insulin sensitivity and glucose tolerance on HFD. (A) Body weight of
Dnmt3aAdiKO and control mice on HFD (n = 7, 9, p<0.05, Student’s t-test, mean ±s.e.m.). (B) Body composition after 10 weeks of HFD (n = 7, 9). (C)
Effect of long-term fasting (16 hr) on body weight or body composition by EchoMRI. Shown is % loss after fasting (n = 14, 14, p<0.05, Student’s t-test,
mean ±s.e.m.). (D) Glucose tolerance test after 9 weeks on HFD (n = 7, 9, p<0.05, Student’s t-test, mean ±s.e.m.). (E) The area under curve (AUC) in (D).
(F) Insulin tolerance test after 11 weeks on HFD (n = 7, 9, p<0.05, Student’s t-test, mean ±s.e.m.). (G) AUC in (F). (H) Fed and fasted insulin levels
measured by ELISA (n = 7, 9 p<0.05, Student’s t-test, mean ±s.e.m.) (I) Immunoblot of total and phospho-AKT and IRS-1 in eWAT after IP insulin. (J)
Quantification of western blot in (I).
DOI: https://doi.org/10.7554/eLife.30766.016
The following source data and figure supplements are available for figure 4:
Source data 1. Figure 4—source data.
DOI: https://doi.org/10.7554/eLife.30766.027
Figure supplement 1. Adipose-specific deletion of Dnmt3a.
DOI: https://doi.org/10.7554/eLife.30766.017
Figure supplement 1—source data 1. Figure 4—figure supplement 1—source data.
DOI: https://doi.org/10.7554/eLife.30766.018
Figure supplement 2. Metabolic features of Dnmt3aAdiKO mice on chow.
DOI: https://doi.org/10.7554/eLife.30766.019
Figure supplement 2—source data 1. Figure 4—figure supplement 2—source data.
DOI: https://doi.org/10.7554/eLife.30766.020
Figure supplement 3. Metabolic features of female Dnmt3aAdiKO on HFD.
DOI: https://doi.org/10.7554/eLife.30766.021
Figure supplement 3—source data 1. Figure 4—figure supplement 3—source data.
DOI: https://doi.org/10.7554/eLife.30766.022
Figure supplement 4. Gene expression profile of thermogenic genes in Dnmt3aAdiKO mice on HFD.
DOI: https://doi.org/10.7554/eLife.30766.023
Figure supplement 4—source data 1. Figure 4—figure supplement 4—source data.
DOI: https://doi.org/10.7554/eLife.30766.024
Figure 4 continued on next page
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overexpressing Dnmt3a, is increased in cells expressing shDnmt3a, and most importantly, is up-regu-
lated in the adipose tissue of Dnmt3aAdiKO mice (Figure 5D). Unlike adipose tissue levels, serum lev-
els of Fgf21 were reduced in HFD-fed Dnmt3aAdiKO mice compared to controls (Figure 5—figure
supplement 5–). To determine whether restoration of FGF21 levels could ameliorate Dnmt3a-medi-
ated IR, we treated 3T3-L1 adipocytes that overexpress Dnmt3a with recombinant FGF21, which
restored insulin sensitivity in a dose-dependent manner (Figure 5E).
Dnmt3a-mediated changes in Fgf21 gene expression involve changes in
DNA methylation
In general, the level of DNA methylation at gene promoters is inversely correlated with mRNA
expression (Jones, 2012). Given the functional significance of FGF21 in Dnmt3a-mediated IR, we fur-
ther examined whether Dnmt3a directly alters methylation of the 5 kb upstream promoter regions of
the Fgf21 gene (Figure 6A). Using methylated DNA precipitation PCR (MeDIP-qPCR), we detected
genomic DNA hypermethylation at Fgf21 promoter regions in Dnmt3a overexpressor 3T3-L1 cells
compared to controls (Figure 6B). Conversely, DNA hypomethylation of these same regions was
seen in Dnmt3a knock-down cells (Figure 6B). In addition to the in vitro models, we conducted
MeDIP-qPCR analysis using genomic DNA from fractionated adipocytes of Dnmt3aAdiKO and control
animals, finding reduced DNA methylation at the Fgf21 promoter in KO cells (Figure 6C). Consistent
with DNA methylation pattern at the Fgf21 promoter region, co-transfection of Dnmt3a potently
inhibited promoter activity of Fgf21 (Figure 6D). Together, these data suggest that Dnmt3a-medi-
ated suppression of Fgf21 involves changes in DNA methylation profile at key promoter regions.
DNA methylation of FGF21 is increased in human adipose tissue of
subjects with type 2 diabetes
To translate some of our findings to humans, we investigated DNA methylation and gene expression
of FGF21 in human adipose tissue collected from diabetic vs. non-diabetic human subjects. In line
with our mouse data, we found hypermethylation of four CpG sites annotated to FGF21 in adipose
tissue of subjects with type 2 diabetes compared with non-diabetic controls (Figure 7A and
Supplementary file 2). Further, we found a negative correlation between DNA methylation and
mRNA expression of FGF21 in human adipose tissue (Figure 7B–E). Together, these data support a
role for increased DNA methylation of FGF21 in the regulation of adipose FGF21 expression in asso-
ciation with metabolic disease.
Discussion
While genetics plays an important role in obesity and T2D, genetic differences cannot fully explain
many features of these conditions, such as discordance in monozygotic twins, and the close relation-
ship with lifestyle factors (McCarthy, 2010; Morris et al., 2012; Voight et al., 2010; Zeggini et al.,
2008). Of note, the vast majority of GWAS-proven allelic variants associated with T2D correspond
much better to altered insulin secretion and islet function rather than to IR per se (Voight et al.,
2010). Hence, forms of non-genetic variation, such as epigenetic alterations, must also be consid-
ered. This notion has been borne out by a recent epigenome-wide association study (EWAS) linking
alterations in DNA methylation to whole-body insulin sensitivity (Zhao et al., 2012). Importantly,
even genetic variants may cause disease in a DNA methylation-dependent manner, as has recently
been shown for T2D and obesity (Dayeh et al., 2013; Elliott et al., 2017; Nilsson et al., 2014;
Olsson et al., 2014; Volkov et al., 2016). We have also shown that adipose tissue from patients
with T2D exhibit numerous methylation and expression differences relative to unrelated healthy con-
trols, with many of the same changes also seen in twin pairs discordant for T2D (Nilsson et al.,
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2014). In this study, we identified increased expression of an enzymatic effector of DNA methylation,
Dnmt3a, as a key epigenetic driver of IR in vitro and in vivo.
DNA methylation, like other forms of epigenomic modification, has been an attractive therapeutic
target because of their plasticity and because they offer an opportunity to reprogram cells into a
more healthy state. For example, administration of pan-inhibitors of histone deacetylase exerts ben-
eficial metabolic effects in both mice and humans, such as increased energy expenditure, insulin sen-
sitivity and secretion (Christensen et al., 2011; Daneshpajooh et al., 2017; Sharma and Taliyan,
2016; Ye, 2013). DNA methyltransferase inhibitors have also been shown to have an insulin-
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Figure 5. Fgf21 is a key target gene of Dnmt3a. Venn diagram showing the number of positive (A) and negative (B) Dnmt3a target genes through
comparative analysis of RNA-seq profiles from Dnmt3a knockdown and overexpressing adipocytes. (C) Heat map showing differentially regulated genes
by Dnmt3a overexpression and knock-down. Group 1: Genes that are down-regulated by Dnmt3a overexpression; Group 2: Genes that are down-
regulated by Dnmt3a overexpression and up-regulated by Dnmt3a knock-down; Group 3: Genes that are up-regulated by Dnmt3a knock-down. (D)
Fgf21 mRNA expression in Dnmt3a overexpressor (left) and knock-down (middle) L1 adipocytes and in fractionated adipocytes (right) from Dnmt3aAdiKO
and Dnmt3af/f mice on HFD (n = 5). (E) Mature 3T3-L1 adipocytes expressing GFP or Dnmt3a treated with indicated amount of recombinant Fgf21 for
48 hr (or vehicle), and tested for insulin sensitivity by 3H-2-DG assay. Shown is basal and insulin-stimulated glucose uptake. (n = 6 mice, p<0.05,
Student’s t-test, mean ±s.e.m.).
DOI: https://doi.org/10.7554/eLife.30766.028
The following source data and figure supplements are available for figure 5:
Source data 1. Figure 5—source data.
DOI: https://doi.org/10.7554/eLife.30766.031
Figure supplement 1. Serum Fgf21 levels in Dnmt3aAdiKO mice.
DOI: https://doi.org/10.7554/eLife.30766.029
Figure supplement 1—source data 1. Figure 5—figure supplement 1—source data.
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sensitizing effect in vivo and in vitro (Kim et al., 2015). In line with pharmacological studies, mutant
mouse models carrying loss-of function histone modifiers (e.g. Mll2, Ehmt1, Jmhd2a Lsd1) were
shown to have profound impact on whole body metabolism (Lee et al., 2006; Ohno et al., 2013;
Sambeat et al., 2016; Tateishi et al., 2009; Zeng et al., 2016). It should be noted that metabolic
consequences in mouse models carrying mutations of histone modifiers appear to be mainly attribut-
able to changes in body weight. Unlike these examples, adipose-specific Dnmt3a KO mice are rela-
tively unique in that they display improved insulin sensitivity without a change in adiposity or body
weight. Similarly, the effect on insulin action is not dependent on increased beige or brown adipo-
cytes, or on reducing intra-adipose inflammation.
Our in vitro study indicates that overexpression of Dnmt3a is sufficient to induce cell autonomous
IR, however, it does not seem to be the case in vivo. Kamei et al showed that transgenic expression
of Dnmt3a per se was not sufficient to render whole body IR and glucose intolerance (Kamei et al.,
2010) on chow, HFD, or high methyl diet with chow diet. Authors observed only a mild increase in
the gene expression of proinflammatory cytokines (i.e. Mcp1 and Tnfa) when animals were put on
HFD. It should be noted that the major caveat of this study is the use of aP2 promoter to drive the
transgene expression (Jeffery et al., 2014; Kang et al., 2014; Lee et al., 2013); Potentially, non-
adipose expression and earlier expression during development might have a compounding factor in
this study. Despite these notions, it will be highly interesting to address how the combination of
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Figure 6. Dnmt3a-mediated methylation of the Fgf21 gene promoter. (A) Schematic showing the tested regions for MeDIP-qPCR at the Fgf21 locus.
Target regions were chosen using MethFinder (http://www.urogene.org/methprimer) on regions proximal (5 kb) and distal (50 kb) to the Fgf21
transcription start site. (B) MeDIP-qPCR was performed using genomic DNA extracted from 3T3-L1 adipocytes transduced with GFP vs. Dnmt3a or
shScr vs. shDnmt3a. Shown is relative fold enrichment of 5mC of Dnmt3a overexpressor and KD cells over control cells. (C) MeDIP-qPCR was performed
using genomic DNA from Dnmt3a KO and Flox mice on HFD. Shown is relative fold enrichment of 5mC of KO over WT samples. (D) Fgf21-promoter
reporter (1497/+5) assay performed by co-transfection of the indicated amounts of Dnmt3a expression vector. (n = 3 mice, p<0.05, Student’s t-test,
mean ±s.e.m.).
DOI: https://doi.org/10.7554/eLife.30766.032
The following source data is available for figure 6:
Source data 1. Figure 6—source data.
DOI: https://doi.org/10.7554/eLife.30766.033
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high methyl donor diet and HFD would affect the metabolic profile of these transgenic animals com-
pared to controls.
Our unbiased gene expression profiling studies led us to identify Fgf21 as a key target gene in
adipocytes, and the data from diabetic humans suggests that this could be a conserved mechanism
of IR in both mice and humans. Fgf21 is better known as a hepatokine, and the liver is the main
source of circulating Fgf21 (Markan et al., 2014) Adipose Fgf21 probably does not circulate, but
rather acts in an autocrine/paracrine manner (Dutchak et al., 2012; Markan et al., 2014). In fact,
levels of Fgf21 in serum were moderately reduced in Dnmt3a KO animals compared to controls, in
contrast to significantly elevated adipose tissue levels. Studies have shown a positive correlation
between insulin and circulating Fgf21 levels (Chavez et al., 2009; Chen et al., 2008; Zhang et al.,
2008), suggesting that insulin may be a key determinant of Fgf21 in serum. Thus, it is possible that
the reduced insulin levels in Dnmt3a KO mice on HFD may have led to reduction of Fgf21 produc-
tion in liver. This notion is in line with the finding that Fgf21 serum levels are often elevated in obe-
sity-associated IR (Fisher and Maratos-Flier, 2016; Morrice et al., 2017), possibly reflecting
resistance to Fgf21 (Fisher et al., 2010).
We propose that the local activity of Fgf21 within the fat pad is important for the improved insulin
sensitivity in the knock-out mice, although formal proof of this idea would require generating adi-
pose tissue-specific Dnmt3a and Fgf21 double knockout mice. In line with this view, there are previ-
ous studies indicating that adipose Fgf21 is insulin-sensitizing. For example, three independent
studies demonstrated that mutant mice devoid of Fgf21 signaling in adipose tissue secondary to
ablation of FGFR1 or bKlotho, were refractory to the insulin-sensitizing effect of Fgf21 administration
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Figure 7. FGF21 DNA methylation in adipose tissue from subjects with T2D compared with controls. (A) Four CpG sites annotated to FGF21 with
significant difference in adipose tissue DNA methylation between subjects with type 2 diabetes and controls. (p<0.01, paired Wilcoxon statistics,
mean ±s.d.). (B–D) Correlations between DNA methylation and mRNA expression for CpG sites significantly associated with T2D in human adipose
tissue. (r = Pearson correlation coefficient.).
DOI: https://doi.org/10.7554/eLife.30766.034
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(Adams et al., 2013; BonDurant et al., 2017; Ding et al., 2012). Some of these studies
(Adams et al., 2013; Ding et al., 2012) suggested that adiponectin is an essential mediator of
Fgf21 metabolic action; the other study (BonDurant et al., 2017) suggested that adiponectin is dis-
pensable. In our studies, albeit it did not reach statistical significance, there was a trend toward
increased mRNA expression of Adipoq in both L1 and primary Dnmt3a KO adipocytes (not shown).
Control of Fgf21 expression appears to be highly tissue-specific. For example, PPARg is an impor-
tant driver of Fgf21 in adipose tissue, while PPARa serves that role in liver (Dutchak et al., 2012).
Other studies have also demonstrated that Fgf21 is positively regulated by PPARg in fat
(Muise et al., 2008; Wang et al., 2008). In addition to focused studies on Fgf21 promoter regions,
global DNA methylation profiling will be necessary to identify differentially methylated regions in
the setting of Dnmt3a gain- and loss-of function.
A recent study demonstrated that Dnmt1 may contribute to obesity-associated inflammation and
insulin resistance by promoting hypermethylation at the Adipoq locus (Kim et al., 2015). Concor-
dant with this study, we also see elevated Dnmt1 levels in the adipose tissue of obese animals. How-
ever, knockdown of Dnmt1 did not rescue insulin sensitivity in the setting of Dex or TNF, and
overexpression of Dnmt1 did not reduce insulin-stimulated glucose uptake in cultured adipocytes.
Based on those criteria, we chose to focus on Dnmt3a, and showed that adipose-specific deletion of
this gene promoted insulin sensitivity even in weight-matched obese animals. Of note, we did not
identify Adipoq as a regulated target after either deletion or overexpression of Dnmt3a.
Despite some effort, we have not yet identified the mechanism by which Dnmt3a expression is
increased in obesity. We found that Dnmt3a is not induced by lipids (e.g. palmitate), pro-inflamma-
tory signals (e.g. IL-6, LPS), high doses of insulin, or high glucose in cultured adipocytes (not shown).
In our study, in vivo administration of thiazolidinediones normalized the expression of Dnmt3a in ob/
ob mice but not in lean control animals. The mechanism by which PPARg represses gene expression
is not entirely clear. Trans-repression through binding of inflammatory transcription factors like NF-k
B and AP-1 has been proposed as a general mechanism for this type of effect (Glass and Saijo,
2010) although we note that there are PPARg binding sites near the Dnmt3a TSS (not shown). It is
thus unclear if direct or indirect (i.e. trans-repression) mechanisms account for the actions of rosigli-
tazone on Dnmt3a expression in obesity.
In summary, we have identified a novel role for Dnmt3a as an epigenetic mediator of adipose IR
in vitro and in vivo. Future studies will be required to fully elucidate the full range of its target geno-
mic regions and metabolic effects.
Materials and methods
Cell culture
3T3-L1 preadipocytes were obtained from ATCC and maintained and differentiated as described
(Kang et al., 2012). These cells were authenticated by the ability to differentiate and confirmed to
be mycoplasma negative. To generate lentivirus particles, lentiviral constructs were co-transfected
with pM2DG- and psPAX-expressing plasmids into 293T cells. After 48 hr, virus-containing superna-
tant was collected, filtered through 0.45 mm filters, and added to mature 3T3-L1 adipocytes for 24
hr along with 8 mg/ml Polybrene. Transduction efficiency was determined by comparison with cells
transduced in parallel with a GFP-expressing lentivirus. For the ex vivo system, subcutaneous adi-
pose tissue from wild-type C57Bl/6 mice was fractionated with digestion buffer (10 mg/ml collage-
nase D, 2.4 units of dispase II, 10 mM CaCl2 in PBS). Cells from the stromal-vascular fraction (SVF)
were plated in culture and differentiated as described previously (Qureshi et al., 2014). To differen-
tiate hASCs, Rosi (5 mM) was added in addition to IBMX (0.5 mM), insulin (5 mg/ml), and dexametha-
sone (1 mM), from day 0–2.
3H-2-DG assay
Mature 3T3-L1 adipocytes were incubated in serum-free DMEM for 4–6 hr. Cells were then washed
three times with KRH buffer (12 mM HEPES, pH 7.4, 121 mM NaCl, 5 mM KCl, 0.33 mM CaCl2, and
1.2 mM MgSO4) and incubated for 20 min in KRH buffer in the absence or presence of 50 nM insulin.
Cells were treated with 2-deoxy-d-[2,6-3H]-glucose (0.33 mCi/ml) for another 10 min. Glucose uptake
was stopped quickly by three rapid washes with KRH buffer containing 200 mM glucose and 10 mM
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cytochalasin B on ice. Cells were solubilized in 0.1% SDS for 30 min, and radioactivity was measured
by liquid scintillation counting.
Reagents
2-Deoxy-d-[2,6-3H]-glucose was purchased from PerkinElmer NEN radiochemicals. Insulin, dexa-
methasone, isobutylmethylxanthine (IBMX), cytochalasin B, glucose, 2-deoxyglucose, 5-Aza, ECCG,
and TF-3 were purchased from Sigma-Aldrich. Recombinant TNF-a and Fgf21 were purchased from
Millipore. RG-108 was purchased from Stemgent.
Antibodies
Antibodies were purchased from Cell Signaling (Dnmt3a, 3598S; Akt, 9272; pAkt [S473], 3787; IRS-1,
2382), and from Thermo Fisher (b-actin, MA5-14739, pIRS1[pY612], 44–816G).
Animals
For rosiglitazone studies, female mice ob/ob and ob/+were treated starting at 8 weeks of age with
rosiglitazone by gavage (10 mg/kg body weight) in 0.5% carboxymethylcellulose versus 0.5% car-
boxymethylcellulose vehicle control daily for 6 weeks. For chow and high-fat feeding studies, male
C57Bl/6J mice were put on diet beginning at 8 weeks of age and continued for three months (n = 8
per dietary condition). Samples were collected from the perigonadal fat pad.
For histology, adipose tissues were fixed with neutral-buffered formalin and embedded in paraffin
and sections were stained with H&E.
For in vivo insulin signaling assay, after overnight fast, insulin (10 U/kg, 5 min) or saline IP were
given to WT and KO mice on HFD. After 10 min various tissues were harvested and stored at –80˚C
until use. Tissue samples were homogenized in cell signaling lysis buffer containing protease inhibi-
tors (Roche) and phosphatase inhibitors (Sigma-Aldrich) and subjected to western blotting. All ani-
mal work was approved by the BIDMC IACUC and/or the UC Berkeley ACUC.
RNA extraction and quantitative PCR
Total RNA was extracted from cells or tissues using TRIzol reagent according to the manufacturer’s
instructions. cDNA was reverse-transcribed from 1 mg of RNA using the RETROscript first strand syn-
thesis kit (Ambion). Quantitative PCR (qPCR) was performed with SYBR Green qPCR Master Mix
(Applied Biosystems) using a 7900HT Fast Real-Time PCR System (Applied Biosystems) and CFX96
Touch (Bio Rad). Primer sequences are listed in Supplementary file 3. The relative amount of mRNA
normalized to cyclophilin B was calculated using the delta–delta method (Livak and Schmittgen,
2001).
Plasmids
Hairpins against Dnmt1, Dnmt3a, and Dnmt3b were purchased from Sigma. Lentiviral overexpres-
sion vectors for Dnmt1, 3a, and 3b were subcloned into pCDH using various multicloning sites (XbaI/
NotI for Dnmt1, EcoRI/NotI for Dnmt1, Dnmt3a, Dnmt3a-CM) and NotI sites and hairpins targeting
Dnmts were subcloned at AgeI/EcoRI or purchased from Open Biosystems. Hairpin sequences are
shown in Supplementary file 3. Fgf21-luc (1497/+5) was generously provided by Dr. Steven Kliewer
(UT Southwestern).
MeDIP-qPCR
Genomic DNA was sheared by sonication to an average of 200–800 bp size. Two microgram of
denatured DNA was incubated with 2 mg of anti-5-methylcytidine antibody (Epigentek) in IP buffer
(10 mM Na-Phosphate pH 7.0, 0.14 M NaCl, 0.05% Triton X-100) for 2 hr at 4˚C. Antibody-bound
DNA was collected with 20 ml of Dynabeads anti-mouse IgG (Invitrogen Dynal, Oslo, Norway) for 1
hr at 4˚C on a rotating wheel and successively washed five times with washing buffer (0.1% SDS, 1%
Triton X-100, 2 mM EDTA, 20 mM Tris-HCl pH 8.1, 150 mM NaCl), and twice with TE (10 mM TrisCl,
1 mM EDTA pH 8.0). DNA was recovered in digestion buffer 125 ml buffer (50 mM Tris pH 8.0, 10
mM EDTA, 0.5% SDS, 35 mg proteinase K) and incubated for 3 hr at 65˚C. Recovered DNA was used
for qPCR analysis. Primers for MeDIP-qPCR studies are listed in Supplementary file 3. All data are
normalized to input.
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RNA-seq studies
mRNA was purified from 100 ng of total RNA using the Ribo-Zero Magnetic Gold Kit (catalog
MRZG126, Illumina). Libraries were prepared using the TruSeq RNA Library Preparation Kit v2 (cata-
log RS-122–2001, Illumina) according to the manufacturer’s protocol starting with the EPF step.
Sequencing was performed on the Illumina HiSeq2500. RNA-Seq data are aligned using TopHat2
(Kim et al., 2013). Reads are assigned to transcripts using featureCounts and an mm9 genome mod-
ified to minimize overlapping transcripts (Liao et al., 2014). Differential expression analysis of the
data is performed using EdgeR (Robinson et al., 2010).
DNA methylation and mRNA expression in human adipose tissue
DNA methylation was analyzed in adipose tissue from 28 subjects with type 2 diabetes and 28 con-
trols as well as in adipose tissue of 14 monozygotic twin pairs (n = 28) using Infinium HumanMethyla-
tion450 BeadChips (Illumina) according to our previous study where we also present the
characteristics of these subjects (Nilsson et al., 2014). Their characteristics are presented in
Supplementary file 4. mRNA was analyzed in adipose tissue from the 12 monozygotic twin pairs
(n = 24) using GeneChip Human Gene 1.0 ST arrays (Affymetrix, Santa Clara, CA) according to the
manufacturer’s recommendations. In the present study, we studied mRNA expression and DNA
methylation of CpG sites annotated to FGF21. DNA and RNA were extracted from human adipose
tissue as presented (Nilsson et al., 2014).
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